Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Defesche

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
BMC Neurology|August 20, 2015
Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity activities in unilateral Cerebral Palsy: a clinical trialLucianne Speth, Yvonne Janssen-Potten, Eugene Rameckers, et al.
Archives of Internal Medicine|October 25, 1993
Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemiaJ C Defesche, K L Pricker, M R Hayden, et al.
European Heart Journal|November 9, 2006
Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemiaOlga W Souverein, Joep C Defesche, Aeilko H Zwinderman, et al.
Human Genetics|April 1, 1989
DNA restriction fragment length polymorphisms in differential diagnosis of genetic disease: application in neuromuscular diseasesJ C Defesche, M de Vissar, E Bakker, et al.
Seminars in Vascular Medicine|June 17, 2004
Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The NetherlandsDavid Wonderling, Marina A W Umans-Eckenhausen, Dalya Marks, et al.
Circulation|May 20, 2025
Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized TrialAlbert Wiegman, Amy L Peterson, Robert A Hegele, et al.
Journal of Epidemiology and Community Health|June 20, 2001
Results from a family and DNA based active identification programme for familial hypercholesterolaemiaA H ten Asbroek, P J de Mheen, J C Defesche, et al.
Molecular Genetics and Metabolism|February 12, 2009
Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analysesØystein L Holla, Sigve Nakken, Morten Mattingsdal, et al.
Nature Reviews. Disease Primers|December 9, 2017
Familial hypercholesterolaemiaJoep C Defesche, Samuel S Gidding, Mariko Harada-Shiba, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemiaS N Pimstone, J C Defesche, S M Clee, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
BMC Neurology|August 20, 2015
Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity activities in unilateral Cerebral Palsy: a clinical trialLucianne Speth, Yvonne Janssen-Potten, Eugene Rameckers, et al.
Archives of Internal Medicine|October 25, 1993
Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemiaJ C Defesche, K L Pricker, M R Hayden, et al.
European Heart Journal|November 9, 2006
Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemiaOlga W Souverein, Joep C Defesche, Aeilko H Zwinderman, et al.
Human Genetics|April 1, 1989
DNA restriction fragment length polymorphisms in differential diagnosis of genetic disease: application in neuromuscular diseasesJ C Defesche, M de Vissar, E Bakker, et al.
Seminars in Vascular Medicine|June 17, 2004
Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The NetherlandsDavid Wonderling, Marina A W Umans-Eckenhausen, Dalya Marks, et al.
Circulation|May 20, 2025
Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized TrialAlbert Wiegman, Amy L Peterson, Robert A Hegele, et al.
Journal of Epidemiology and Community Health|June 20, 2001
Results from a family and DNA based active identification programme for familial hypercholesterolaemiaA H ten Asbroek, P J de Mheen, J C Defesche, et al.
Molecular Genetics and Metabolism|February 12, 2009
Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analysesØystein L Holla, Sigve Nakken, Morten Mattingsdal, et al.
Nature Reviews. Disease Primers|December 9, 2017
Familial hypercholesterolaemiaJoep C Defesche, Samuel S Gidding, Mariko Harada-Shiba, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemiaS N Pimstone, J C Defesche, S M Clee, et al.
Pageof 18